Skip to content

Clinical trials

Phase 1 Cognitive Dysfunction trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Phase: Phase 1 Country / region: United States Clear all

99 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20044
20062
20071
20081
20092
20103
20111
20126
20132
20143
20156
20165
20174
20185
20196
20205
20219
20226
20238
20243
20255
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Recruiting15
Terminated8
Active, not recruiting7
Not yet recruiting5
Unknown status5
Withdrawn4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
Johns Hopkins University4
Suven Life Sciences Limited4
Mclean Hospital3
Oregon Health and Science University3
Posit Science Corporation3
Massachusetts General Hospital2
Mayo Clinic2
NYU Langone Health2
National Institute of Mental Health (NIMH)2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction99
Alzheimer Disease36
Dementia15
Memory Disorders7
Cognition Disorders4
Inflammation4
Parkinson Disease4
Mental Disorders3
Neurocognitive Disorders3
Neurodegenerative Diseases3

Trials

Showing 1 to 25 of 99. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.